Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Collet

Showing results (31-40 of 408) with videos related to

Pageof 41
Sort By:
The New England Journal of Medicine|March 1, 2013
Bedside monitoring of antiplatelet therapy for coronary stentingGilles Montalescot, Eric Vicaut, Jean-Philippe Collet
Journal of the American College of Cardiology|May 14, 2016
Individualized Modeling Approach for DAPT Duration: Vision or Confusion?Jean-Philippe Collet, Quentin Fischer, Gilles Montalescot
European Heart Journal|November 14, 2020
Optimal timing of invasive angiography in non-ST-segment elevation acute coronary syndromes-do we need more data?Alexander Jobs, Jean-Philippe Collet, Holger Thiele
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 19, 2015
Antithrombotic therapy in TAVI patients: changing conceptsGiuseppe Gargiulo, Jean-Philippe Collet, Marco Valgimigli
Circulation. Cardiovascular Interventions|May 31, 2015
Platelet function test-guided strategy: lost in translation?Jean-Philippe Collet, Johanne Silvain, Gilles Montalescot
European Heart Journal|April 12, 2014
Contrast-induced nephropathy: the sin of primary percutaneous coronary intervention?Johanne Silvain, Jean-Philippe Collet, Gilles Montalescot
Journal of the American College of Cardiology|October 19, 2019
Aspirin-Free Strategies After PCI: Still Not Out of the TwilightJean-Philippe Collet, Gilles Montalescot, Michel Zeitouni
JACC. Cardiovascular Interventions|May 24, 2023
VARC-3 Criteria: Adding Prognosis to InjuryPaul Guedeney, Gabriel Chevrot, Jean-Philippe Collet
JACC. Cardiovascular Interventions|August 20, 2016
The Triple Challenge of Triple TherapyJean-Philippe Collet, Paul Guedeney, Gilles Montalescot
Purinergic Signalling|June 29, 2011
The P2Y(12) receptor as a target of antithrombotic drugsStephen O'Connor, Gilles Montalescot, Jean-Philippe Collet
Pageof 41

Showing results (31-40 of 408) with videos related to

Sort By:
Pageof 41
The New England Journal of Medicine|March 1, 2013
Bedside monitoring of antiplatelet therapy for coronary stentingGilles Montalescot, Eric Vicaut, Jean-Philippe Collet
Journal of the American College of Cardiology|May 14, 2016
Individualized Modeling Approach for DAPT Duration: Vision or Confusion?Jean-Philippe Collet, Quentin Fischer, Gilles Montalescot
European Heart Journal|November 14, 2020
Optimal timing of invasive angiography in non-ST-segment elevation acute coronary syndromes-do we need more data?Alexander Jobs, Jean-Philippe Collet, Holger Thiele
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 19, 2015
Antithrombotic therapy in TAVI patients: changing conceptsGiuseppe Gargiulo, Jean-Philippe Collet, Marco Valgimigli
Circulation. Cardiovascular Interventions|May 31, 2015
Platelet function test-guided strategy: lost in translation?Jean-Philippe Collet, Johanne Silvain, Gilles Montalescot
European Heart Journal|April 12, 2014
Contrast-induced nephropathy: the sin of primary percutaneous coronary intervention?Johanne Silvain, Jean-Philippe Collet, Gilles Montalescot
Journal of the American College of Cardiology|October 19, 2019
Aspirin-Free Strategies After PCI: Still Not Out of the TwilightJean-Philippe Collet, Gilles Montalescot, Michel Zeitouni
JACC. Cardiovascular Interventions|May 24, 2023
VARC-3 Criteria: Adding Prognosis to InjuryPaul Guedeney, Gabriel Chevrot, Jean-Philippe Collet
JACC. Cardiovascular Interventions|August 20, 2016
The Triple Challenge of Triple TherapyJean-Philippe Collet, Paul Guedeney, Gilles Montalescot
Purinergic Signalling|June 29, 2011
The P2Y(12) receptor as a target of antithrombotic drugsStephen O'Connor, Gilles Montalescot, Jean-Philippe Collet
Pageof 41